Muscle loss on a GLP-1, and how to limit it
Between roughly a quarter and a third of the weight lost on a GLP-1 can be lean mass rather than fat, and at higher doses without resistance training that share can be greater. This is not unique to these medicines — all rapid weight loss costs muscle — but the speed and magnitude here make it more consequential. The two things that reliably change the outcome are protein at 1.2 to 1.6 g per kilogram daily and resistance training two or three times a week. Older adults are at the greatest risk and benefit most from getting both right.
What the body composition data shows
Weight loss is never purely fat. In most dietary interventions, somewhere between 20 and 30 per cent of what comes off is lean tissue, and that has been understood for decades.
GLP-1 body composition sub-studies land broadly in the same range, with estimates commonly cited between a quarter and around a third of total weight lost. Some analyses at higher doses have reported more. The figures vary considerably depending on the measurement method, the population and whether participants were doing any resistance training, which is why you will see a wide spread quoted.
The honest summary: it is a real and substantial effect, it is not unique to these drugs, and the range is wide because the modifiable factors matter enormously.
Why lean mass matters beyond appearance
Three reasons, and only one of them is visible in a mirror.
- Resting energy expenditure. Muscle burns calories at rest. Losing it lowers the floor, which makes maintaining your new weight harder.
- Glucose handling. Skeletal muscle is where most glucose is disposed of. Less of it is metabolically unhelpful, particularly if the reason for treatment was diabetes.
- Physical function. Standing from a chair, climbing stairs, carrying shopping, recovering from a fall. This is the one that determines quality of life later.
Why age changes the calculation
Adults lose muscle mass steadily from around the fourth decade, at roughly 3 to 8 per cent per decade, accelerating after 60. That decline is happening anyway, before any medication is involved.
Layer rapid weight loss on top and the combined effect can be substantial. There is a recognised condition, sarcopenic obesity, where someone carries excess fat and inadequate muscle simultaneously, and it is associated with worse outcomes than either alone.
This is not an argument against treating obesity in older adults, which has clear benefits. It is an argument for doing it with protein and resistance training attached, and for slower rather than faster where there is a choice.
How to tell whether it is happening to you
The scale cannot distinguish fat from muscle, and neither can a tape measure. There are three practical options, in ascending order of accuracy.
- Function. Are ordinary things getting harder? Stairs, shopping, standing from low chairs. Crude but genuinely informative.
- Grip strength. Correlates reasonably well with total muscle mass, and some clinics measure it. Cheap and quick.
- A DEXA scan. The reliable answer. Available privately in Ireland for roughly €100 to €150. A baseline scan and one six months later tells you exactly what you have lost.
A baseline DEXA before starting is a genuinely useful investment if you are older, already lean-ish, or planning to be on treatment for years.
What actually prevents it
Two things, and the evidence for both is much stronger than for anything else being marketed at this problem.
Protein, 1.2 to 1.6 g per kilogram of body weight daily. This is difficult on a suppressed appetite and it is where most people fall short without realising. Protein first at every meal is the single most useful habit.
Resistance training, two or three sessions a week. Protein supplies the raw material; loading the muscle is what tells your body to keep it. Neither works nearly as well alone.
A third, less discussed: rate of loss. Faster is not better. If you are losing very rapidly at a high dose, a slower approach at a lower dose preserves more lean mass, and that is a legitimate conversation to have with your prescriber.
What is coming
Muscle preservation has become one of the most active areas in obesity research, and several compounds intended to be used alongside GLP-1s to protect or build lean mass are in clinical development.
None is licensed, none is available in Ireland, and none should be bought from anywhere claiming otherwise. It is worth knowing the field is moving, and worth being sceptical of anything sold today on the strength of trials that have not finished.
The thing to take away
A 6 per cent weight loss with muscle intact is a better clinical outcome than 9 per cent without it, even though the scale disagrees and nobody congratulates you for it.
If you do nothing else differently, eat protein first and pick up something heavy twice a week.
Muscle loss on Ozempic: common questions
Body composition studies commonly report between a quarter and around a third of total weight lost as lean mass, with higher figures at higher doses without resistance training. The range is wide because protein intake and training change the outcome substantially.
Not necessarily. Muscle can be rebuilt with resistance training and adequate protein, though it is considerably easier to preserve it than to regain it, and harder with age. Preventing the loss in the first place is the far better strategy.
The scale cannot tell you. Practical indicators are whether everyday tasks are getting harder and whether grip strength is falling. The reliable answer is a DEXA scan, available privately in Ireland for roughly 100 to 150 euro, ideally at baseline and again six months later.
Yes. Adults lose muscle steadily from the fourth decade, accelerating after 60, and rapid weight loss compounds it. This is not a reason to avoid treatment, which has clear benefits, but it is a strong reason to combine it with protein and resistance training.
Yes. Muscle is metabolically active, so losing it lowers your resting energy expenditure. That makes maintaining your new weight harder and makes regain faster if you come off treatment, because you are maintaining on a lower metabolic floor.
Several compounds intended to preserve or build lean mass alongside GLP-1s are in clinical development, but none is licensed or available in Ireland. Anything sold today on the strength of unfinished trials should be treated with scepticism.